HOOK - HOOKIPA Pharma Inc.
IEX Last Trade
1.885
0.085 4.509%
Share volume: 750
Last Updated: Fri 27 Dec 2024 07:57:50 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.80
0.09
4.72%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-14 | 2023-03-15 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-22 | 2024-05-09 | |
| Total revenue | 2.746 M | 2.230 M | 7.828 M | 3.176 M | 2.679 M | 6.867 M | 7.407 M | 36.599 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.746 M | 2.230 M | 7.828 M | 3.176 M | 2.679 M | 6.867 M | 7.407 M | 36.599 M | |
| -18.79% | 251.03% | -59.43% | -15.65% | 156.33% | 7.86% | 394.11% | |||
| Operating expenses | 21.173 M | 23.223 M | 21.416 M | 25.833 M | 24.151 M | 29.537 M | 25.536 M | 24.224 M | |
| Selling general and admin | 5.026 M | 4.937 M | 3.824 M | 4.902 M | 4.445 M | 4.912 M | 4.374 M | 4.056 M | |
| Research and development | 16.147 M | 18.286 M | 17.592 M | 20.931 M | 19.706 M | 24.625 M | 21.162 M | 20.168 M | |
| Total expenses | 21.173 M | 23.223 M | 21.416 M | 25.833 M | 24.151 M | 29.537 M | 25.536 M | 24.224 M | |
| 9.68% | -7.78% | 20.62% | -6.51% | 22.30% | -13.55% | -5.14% | |||
| Operating income | -18.427 M | -20.993 M | -13.588 M | -22.657 M | -21.472 M | -22.670 M | -18.129 M | 12.375 M | |
| Ebit | -18.427 M | -20.993 M | -13.588 M | -22.657 M | -21.472 M | -22.670 M | -18.129 M | 12.375 M | |
| Pretax income | -16.355 M | -18.280 M | -12.082 M | -19.475 M | -18.016 M | -19.066 M | -24.655 M | 14.383 M | |
| 11.77% | -33.91% | 61.19% | -7.49% | 5.83% | 29.31% | -158.34% | |||
| Income tax | 1.000 K | 0.000 | 229.000 K | 205.000 K | 0.000 | 0.000 | 163.000 K | 0.000 | |
| Net income basic | -16.356 M | -18.280 M | -12.311 M | -19.680 M | -18.016 M | -19.066 M | -24.818 M | 14.383 M | |
| -11.76% | 32.65% | -59.86% | 8.46% | -5.83% | -30.17% | 157.95% | |||
| Net income | -16.356 M | -18.280 M | -12.311 M | -19.680 M | -18.016 M | -19.066 M | -24.818 M | 14.383 M | |
| -11.76% | 32.65% | -59.86% | 8.46% | -5.83% | -30.17% | 157.95% |